Livzon Pharmaceutical Group Inc: V-01-351/V-01D

Vaccine Type: Protein Subunit

This vaccine may also be referred to as V-01-351/V-01D Bivalence Vaccine

Vaccine Trial & Approval Tracker

This vaccine has reached Phase 2 trials.

About Trial Phases

Phase 1: 1 Trial

Phase 2: 1 Trial

Phase 3: 0 Trials

There are no trials for this phase.


This vaccine is not yet approved.

Registered Trials